This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

D. C. BLEIL, M.D.

AMA Arch Derm. 1958;77(1):106-107.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A 42-year-old white woman, with chronic, discoid lupus erythematosus of 12 years' duration, was found to be intolerant (acute gastroenteritis) of all previously tried antimalarials. Because of recent reports¹ on the use of amodiaquin (Camoquin) it was felt judicious to institute such therapy in this patient.

The patient presented multiple, well-defined, atrophic, depigmented scars of the face, coupled with active erythematous, defined scaling plaques. Blood studies on many occasions were essentially negative.

Amodiaquin therapy was instituted. Within 10 days of the institution of such therapy total resolution of all cutaneous lesions had occurred and dosage was reduced to maintenance levels. Approximately 18 days after the onset of amodiaquin therapy the patient developed a gradually progressive icterus type of pigmentation noted in all skin areas and the sclera. Associated with this was marked lethargy, anorexia, amenorrhea, and partial blindness. Studies at this time . . . [Full Text PDF of this Article]

Author Affiliations
Milwaukee

Footnotes
Received for publication Aug. 16, 1957.

Consultant Dermatologist, Veterans' Administration Regional Office.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?